Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 17.32%353.38M | 39.53%615.48M | 33.94%301.2M | 75.86%441.13M | 89.29%224.87M | 83.71%250.83M | 129.83%118.8M | 253.21%136.53M | 263.01%51.69M | 106.72%38.66M |
| Operating income | 17.32%353.38M | 39.53%615.48M | 33.94%301.2M | 75.86%441.13M | 89.29%224.87M | 83.71%250.83M | 129.83%118.8M | 253.21%136.53M | 263.01%51.69M | 106.72%38.66M |
| Cost of sales | -28.44%-105.76M | -57.11%-181.86M | -58.60%-82.34M | -55.10%-115.76M | -45.84%-51.91M | -82.56%-74.63M | -149.12%-35.6M | -204.35%-40.88M | -170.37%-14.29M | -100.90%-13.43M |
| Operating expenses | -28.44%-105.76M | -57.11%-181.86M | -58.60%-82.34M | -55.10%-115.76M | -45.84%-51.91M | -82.56%-74.63M | -149.12%-35.6M | -204.35%-40.88M | -170.37%-14.29M | -100.90%-13.43M |
| Gross profit | 13.14%247.62M | 33.27%433.62M | 26.54%218.87M | 84.66%325.37M | 107.88%172.96M | 84.21%176.2M | 122.47%83.2M | 279.23%95.65M | 317.69%37.4M | 109.96%25.22M |
| Selling expenses | 4.29%-145.07M | -1.03%-328.34M | 11.93%-151.57M | -34.50%-324.98M | -85.71%-172.09M | -159.12%-241.63M | -327.46%-92.67M | -341.41%-93.25M | -319.97%-21.68M | -182.36%-21.13M |
| Administrative expenses | -0.19%-62.75M | -6.68%-151.1M | -0.39%-62.63M | -14.75%-141.64M | -4.65%-62.38M | -7.87%-123.43M | -12.30%-59.61M | 3.01%-114.43M | 18.74%-53.08M | 31.95%-117.97M |
| Research and development expenses | -15.08%-115.64M | 30.67%-203.42M | 41.34%-100.48M | 21.36%-293.42M | -105.32%-171.3M | 16.32%-373.13M | 36.46%-83.43M | -331.36%-445.88M | -218.95%-131.29M | -87.48%-103.37M |
| Special items of operating profit | -32.00%7.5M | 153.17%9.89M | 2,338.34%11.04M | -96.73%3.91M | -101.13%-493K | 392.04%119.44M | 328.33%43.75M | 78.07%-40.9M | -538.59%-19.16M | -6,214.83%-186.48M |
| Operating profit | 19.40%-68.32M | 44.44%-239.35M | 63.66%-84.77M | 2.66%-430.76M | -114.53%-233.31M | 26.09%-442.55M | 42.10%-108.75M | -48.32%-598.8M | -91.01%-187.81M | -77.91%-403.72M |
| Financing income | -68.92%5.11M | -43.00%22.48M | -25.21%16.43M | -15.42%39.44M | 21.49%21.97M | 88.24%46.63M | 39.29%18.08M | -26.29%24.77M | 64.14%12.98M | 752.03%33.6M |
| Financing cost | -4,305.30%-5.82M | -2,560.67%-4.74M | -0.76%-132K | 92.31%-178K | 88.31%-131K | -1,145.16%-2.32M | -229.71%-1.12M | 99.19%-186K | 98.52%-340K | -2,696.72%-23.02M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -443.69%-1.68B |
| Earning before tax | -0.81%-69.03M | 43.40%-221.6M | 67.62%-68.48M | 1.69%-391.5M | -130.38%-211.47M | 30.65%-398.24M | 47.60%-91.79M | 72.24%-574.22M | 90.21%-175.17M | -288.86%-2.07B |
| Tax | 23.50%-2.15M | -555.04%-6.89M | -365.78%-2.8M | 89.01%-1.05M | -213.54%-602K | ---9.57M | ---192K | ---- | ---- | ---- |
| After-tax profit from continuing operations | 0.15%-71.18M | 41.79%-228.49M | 66.39%-71.28M | 3.74%-392.55M | -130.55%-212.08M | 28.98%-407.81M | 47.49%-91.99M | 72.24%-574.22M | 90.21%-175.17M | -288.86%-2.07B |
| Earning after tax | 0.15%-71.18M | 41.79%-228.49M | 66.39%-71.28M | 3.74%-392.55M | -130.55%-212.08M | 28.98%-407.81M | 47.49%-91.99M | 72.24%-574.22M | 90.21%-175.17M | -288.86%-2.07B |
| Minority profit | -12,880.00%-1.3M | -6,742.86%-1.92M | 28.57%-10K | ---28K | ---14K | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 1.95%-69.88M | 42.28%-226.58M | 66.39%-71.27M | 3.75%-392.53M | -130.54%-212.06M | 28.98%-407.81M | 47.49%-91.99M | 72.24%-574.22M | 90.21%-175.17M | -288.86%-2.07B |
| Basic earnings per share | 0.00%-0.1 | 41.38%-0.34 | 67.74%-0.1 | 4.92%-0.58 | -121.43%-0.31 | 29.07%-0.61 | 48.15%-0.14 | 80.59%-0.86 | 96.89%-0.27 | -90.13%-4.43 |
| Diluted earnings per share | 0.00%-0.1 | 41.38%-0.34 | 67.74%-0.1 | 4.92%-0.58 | -121.43%-0.31 | 29.07%-0.61 | 48.15%-0.14 | 80.59%-0.86 | 96.89%-0.27 | -90.13%-4.43 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.